Kenney Christopher Johninsider trades

In SEC Form 4 filings, Kenney Christopher John is listed as Chief Medical Officer of Xenon Pharmaceuticals Inc. (XENE). In the last 90 days, Kenney Christopher John sold $425.8K of Xenon Pharmaceuticals Inc. (XENE) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
XENEXenon Pharmaceuticals Inc.	Chief Medical Officer	2	Aug 31

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-31

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
XENEXenon Pharmaceuticals Inc.	Aug 28	Aug 31	S	6,368	$60.17	Sale −$383,145	702	Yes	Form 4
XENEXenon Pharmaceuticals Inc.	Aug 28	Aug 31	S	700	$60.98	Sale −$42,684	2	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.